Cannabix Technologies, Inc. is a technology company that has developed Cannabix Marijuana Breathalyzer for law enforcement. Formerly named West Point Resources, Inc., Cannabix has the exclusive licenses for Cannabix Marijuana Breathalyzer in North America.
The Cannabix Marijuana Breathalyzer is an innovative drug-impairment detection device created based on a breath-testing technology developed in Sweden. This technology underwent rigorous clinical researches to be become highly effective in testing individuals for their recent consumption of Tetrahydrocannabinol (THC), marijuana’s psychoactive component that causes intoxication.
Cannabix Technologies, Inc. focuses on advancing their patent-pending drug-impairment detection technology to provide law enforcement personnel with enhanced marijuana detection capability. This cutting-edge technology will allow law enforcement to efficiently detect marijuana-related impaired driving offenses on roadsides in North America at a time when many jurisdictions are legalizing cannabis use.
The Cannabix Marijuana Breathalyzer is used at roadsides to detect traces of THC in the system of drivers believed to be intoxicated by marijuana. This innovative device may also be used for other applications, including THC testing on employees in workplaces where impairment by marijuana is considered hazardous.
Based in Vancouver, BC, Cannabix Technologies, Inc. is traded on the Canadian Securities Exchange under the symbol BLO, and on the OTC market under the stock symbol BLOZF. The company’s leaders are Kal Malhi, President & Director; Raj Attariwala, Chief Engineer; Bruce Goldberger, Senior Advisor; Ray Mlait, CEO & Director; Jay Bala, Director; Alex Kanayev, Director; Thomas Clarke, Director; and Andrew Davies, Advisor.
Cannabix Technologies, Inc.
7934 Government Rd
Burnaby, BC, V5A 2E2
Phone: (604) 551-7831
Yahoo! Finance: BLOZF News
Latest Financial News for BLOZF
Seattle, Washington--(Newsfile Corp. - October 15, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces the publication of an article covering Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF) and its development of the Cannabix Marijuana Breathalyzer.With cannabis legalization sweeping across North America after decades of prohibition, there are some natural concerns surrounding the introduction of the drug to the legal marketplace. ...
Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer is pleased to report that the Company has entered into an exclusive license agreement with the University of British Columbia (“UBC”) to use and commercialize certain technology for the detection of volatile organic compounds for testing (to be used for marijuana breathalyzer purposes) owned by UBC developed by Dr. Mina Hoofar and her team of researchers at the UBC Okanagan School of Engineering. The patent pending UBC technology known as a “THC Breath Analyzer” (“THCBA”) incorporates highly sensitive microfluidic sensors that can be manufactured at relatively low cost.
Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that Company scientists have developed proprietary methods resulting in the achievement of the highest ∆9-tetrahydrocannabinol (“THC”) detection levels collected from human breath to date. Over the last several months, Company scientists have studied the unique chemical interactions of THC and cannabinoids in breath, and developed and evaluated novel methods to efficiently and practically capture and ionize THC and cannabinoid analytes collected from several different subjects.
The Cannabix Marijuana Breathalyzer is being developed to provide law enforcement and employers a tool to enforce public safety. VANCOUVER, British Columbia, July 15, 2019 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company” or “Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that Company scientists have made significant advancements with analyte in breath capture and FAIMS cell development. Cannabix scientists have been optimizing the breath / sample capture procedures and technology to maximize ∆9-tetrahydrocannabinol (“THC”) analyte capture from human breath.
The Cannabix Marijuana Breathalyzer system is being developed to give law enforcement and employers a tool to enforce public safety. VANCOUVER, British Columbia, May 29, 2019 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that Company engineers have made a significant breakthrough with the ionization module which is a vital component of the breathalyzer device, where breath samples are ionized prior to entrance into the FAIMS cell. The Company also reports that it has been steadily progressing with human breath testing at its Vancouver, BC, based lab with its FAIMS (field asymmetric waveform ion mobility spectrometry) ∆9-tetrahydrocannabinol (“THC”) detection device and breath collection unit (“BCU”).